Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012

Tablet Formulation Development (2 day)

03 Dec 2012 - 04 Dec 2012 - London, UK

Bookmark and Share

This unique course introduces and integrates the key elements of tablet development with the principles of Quality by Design (QbD) with 2 days of theory plus an optional practical day in our development laboratory. It will include experimental, hands-on experience of formulation development using the Gamlen Tablet Press.

Topics include:

·    Applying Quality by Design at the development phase

·    Relating drug substance properties to desired formulation characteristics

·    Development formula and process - how these are linked

·    Identifying processes which will minimise development and manufacturing costs

·    Developing the Product Control Strategy - Critical Quality Attributes and Critical Process Parameters

·    Using novel science - PAT, NIR, Atomic Force Microscope, real time particle analysis

Proper integration of all of these elements is essential to achieve 'Quality by Design' because data from each phase is used to control the next step in the development process. By achieving proper integration based on sound scientific principles, many development and production problems can be avoided.


The course includes case studies of tablet formulation development and a detailed step by step analysis of all elements of the tablet manufacturing process. Hands on, practical studies will underpin the scientific learning in this participative course.

Who should attend?
The course is designed for people new to tablet development, and those requiring a refresher in the area. It will also benefit Process Development experts wishing to extend their understanding of why products processes can go wrong, and regulatory and quality personnel who need to understand the development process.

Course Programme:
Day 1 The Product Development Lifecycle
. Making sense of ICH Q8, 9 and 10—moving from theory to practice
. Designing formulations and processes to meet the Target Product Profile
. Formulation development—Formula and process selection
. Product Optimisation and the formulation cycle
. Developing Product Control Strategies at the formulation development phase
. Tablet Film Coating polymers
Day 2 Advance characterisation and development techniques
. Formulation mapping using X-ray and Raman spectroscopy
. AFM in formulation development
. Real time particle size analysis
. Dryer control using NIR
. Blend uniformity assessment using NIR and other techniques
. Compressibility comparison using the Gamlen Tablet Press
. Characterisation of tablet coats using THz spectroscopy
Day 3 Formulation development in practice (BOOK SEPARATELY) (HANDS ON. LIMITED TO 10 participants only)
. Material characterisation for product development
. Direct compression
. Wet granulation
. Drying
. Milling
. Compression
. Formulation evaluation and final selection
Wherever possible participants should bring practical problems and examples which can be reviewed on the course. The course will be highly participative and useful for people with or without formulation experience.

Course Speakers: Dr Michael Gamlen and Dr Dipankar Dey

Further information
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos